title: US Department of Defense contributions to malaria surveillance.
authors.forename: David
authors.initials: D
authors.lastname: Saunders
authors.forename: Christopher
authors.initials: C
authors.lastname: Duplessis
authors.forename: Andres
authors.initials: A
authors.lastname: Lescano
authors.forename: Ben
authors.initials: B
authors.lastname: Andagalu
authors.forename: Alaina
authors.initials: A
authors.lastname: Thomas
authors.forename: Mark
authors.initials: M
authors.lastname: Fukuda
authors.forename: James
authors.initials: J
authors.lastname: Cummings
mesh_terms: D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage*; D037621:Artemisinins / Q000008:administration & dosage*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000469:parasitology*; D008297:Male; D010963:Plasmodium falciparum / Q000187:drug effects*
chemical_list: D000962:Antimalarials; D037621:Artemisinins
references.citation: Malar J. 2009 Jan 12;8:10
references.pmid: 19138388
references.citation: Lancet Infect Dis. 2012 Nov;12(11):851-8
references.pmid: 22940027
references.citation: Lancet Infect Dis. 2012 Nov;12(11):888-96
references.pmid: 23099083
references.citation: Malar J. 2011 Nov 10;10:339
references.pmid: 22074219
references.citation: J Infect Dis. 2010 Feb 15;201(4):570-9
references.pmid: 20085495
references.citation: N Engl J Med. 2008 Dec 11;359(24):2619-20
references.pmid: 19064625